View in EDS HTML Full Text PDF Full Text

A Phase 1 Randomized, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Enteric-Coated Stabilized Sulforaphane (SFX-01) in Male Participants.

Saved in:
Bibliographic Details
Title: A Phase 1 Randomized, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Enteric-Coated Stabilized Sulforaphane (SFX-01) in Male Participants.
Authors: Clack G; TheraCryf PLC (Formerly Evgen Pharma PLC), Block 24, Alderley Park, Congleton Road, Nether Alderley, Cheshire, SK10 4TG, UK. G.Clack@theracryf.com., Moore C; Boyds, Crewe, UK., Ruston L; Seda Pharmaceutical Development Services, Stockport, UK., Wilson D; DJWstats Consulting, Whaley Bridge, UK., Koch A; Simbec-Orion, Merthyr Tydfil, UK., Webb D; Simbec-Orion, Merthyr Tydfil, UK., Mallard N; TheraCryf PLC (Formerly Evgen Pharma PLC), Block 24, Alderley Park, Congleton Road, Nether Alderley, Cheshire, SK10 4TG, UK.
Source: Advances in therapy [Adv Ther] 2025 Jan; Vol. 42 (1), pp. 216-232. Date of Electronic Publication: 2024 Nov 09.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39520658
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Phase 1 Randomized, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Enteric-Coated Stabilized Sulforaphane (SFX-01) in Male Participants.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Clack+G%22">Clack G</searchLink>; TheraCryf PLC (Formerly Evgen Pharma PLC), Block 24, Alderley Park, Congleton Road, Nether Alderley, Cheshire, SK10 4TG, UK. G.Clack@theracryf.com.<br /><searchLink fieldCode="AU" term="%22Moore+C%22">Moore C</searchLink>; Boyds, Crewe, UK.<br /><searchLink fieldCode="AU" term="%22Ruston+L%22">Ruston L</searchLink>; Seda Pharmaceutical Development Services, Stockport, UK.<br /><searchLink fieldCode="AU" term="%22Wilson+D%22">Wilson D</searchLink>; DJWstats Consulting, Whaley Bridge, UK.<br /><searchLink fieldCode="AU" term="%22Koch+A%22">Koch A</searchLink>; Simbec-Orion, Merthyr Tydfil, UK.<br /><searchLink fieldCode="AU" term="%22Webb+D%22">Webb D</searchLink>; Simbec-Orion, Merthyr Tydfil, UK.<br /><searchLink fieldCode="AU" term="%22Mallard+N%22">Mallard N</searchLink>; TheraCryf PLC (Formerly Evgen Pharma PLC), Block 24, Alderley Park, Congleton Road, Nether Alderley, Cheshire, SK10 4TG, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2025 Jan; Vol. 42 (1), pp. 216-232. <i>Date of Electronic Publication: </i>2024 Nov 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39520658
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12325-024-03018-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 216
    Titles:
      – TitleFull: A Phase 1 Randomized, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Enteric-Coated Stabilized Sulforaphane (SFX-01) in Male Participants.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Clack G
      – PersonEntity:
          Name:
            NameFull: Moore C
      – PersonEntity:
          Name:
            NameFull: Ruston L
      – PersonEntity:
          Name:
            NameFull: Wilson D
      – PersonEntity:
          Name:
            NameFull: Koch A
      – PersonEntity:
          Name:
            NameFull: Webb D
      – PersonEntity:
          Name:
            NameFull: Mallard N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2025 Jan
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1865-8652
          Numbering:
            – Type: volume
              Value: 42
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Advances in therapy
              Type: main
ResultId 1